Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Stuckey

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
JACC. Cardiovascular Interventions|July 25, 2009
Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) TrialEugenia Nikolsky, Roxana Mehran, H Mehrdad Sadeghi, et al.
Circulation|August 27, 2003
Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trialJames E Tcheng, David E Kandzari, Cindy L Grines, et al.
The American Journal of Cardiology|January 16, 2007
Usefulness of routine unfractionated heparin infusion following primary percutaneous coronary intervention for acute myocardial infarction in patients not receiving glycoprotein IIb/IIIa inhibitorsKishore J Harjai, Gregg W Stone, Cindy L Grines, et al.
The American Journal of Cardiology|October 1, 2003
Feasibility and implications of an early discharge strategy after percutaneous intervention with abciximab in acute myocardial infarction (the CADILLAC Trial)David E Kandzari, James E Tcheng, David J Cohen, et al.
Journal of the American College of Cardiology|September 19, 2003
Outcomes of optimal or "stent-like"balloon angioplasty in acutemyocardial infarction: the CADILLAC trialDavid A Cox, Gregg W Stone, Cindy L Grines, et al.
The American Journal of Cardiology|October 30, 2003
Outcomes of bail-out stenting for suboptimal balloon angioplasty during primary intervention in acute myocardial infarction (The CADILLAC trial)Dale T Ashby, Eve A Aymong, Cindy L Grines, et al.
The American Journal of Cardiology|July 25, 2006
Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial)David A Cox, Gregg W Stone, Cindy L Grines, et al.
American Heart Journal|June 20, 2006
Relationship between infarct artery location, epicardial flow, and myocardial perfusion after primary percutaneous revascularization in acute myocardial infarctionDavid E Kandzari, James E Tcheng, Bernard J Gersh, et al.
Journal of the American College of Cardiology|September 15, 2004
Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trialMichael G McLaughlin, Gregg W Stone, Eve Aymong, et al.
Journal of the American College of Cardiology|July 21, 2004
Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarctionCostantino O Costantini, Gregg W Stone, Roxana Mehran, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
JACC. Cardiovascular Interventions|July 25, 2009
Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) TrialEugenia Nikolsky, Roxana Mehran, H Mehrdad Sadeghi, et al.
Circulation|August 27, 2003
Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trialJames E Tcheng, David E Kandzari, Cindy L Grines, et al.
The American Journal of Cardiology|January 16, 2007
Usefulness of routine unfractionated heparin infusion following primary percutaneous coronary intervention for acute myocardial infarction in patients not receiving glycoprotein IIb/IIIa inhibitorsKishore J Harjai, Gregg W Stone, Cindy L Grines, et al.
The American Journal of Cardiology|October 1, 2003
Feasibility and implications of an early discharge strategy after percutaneous intervention with abciximab in acute myocardial infarction (the CADILLAC Trial)David E Kandzari, James E Tcheng, David J Cohen, et al.
Journal of the American College of Cardiology|September 19, 2003
Outcomes of optimal or "stent-like"balloon angioplasty in acutemyocardial infarction: the CADILLAC trialDavid A Cox, Gregg W Stone, Cindy L Grines, et al.
The American Journal of Cardiology|October 30, 2003
Outcomes of bail-out stenting for suboptimal balloon angioplasty during primary intervention in acute myocardial infarction (The CADILLAC trial)Dale T Ashby, Eve A Aymong, Cindy L Grines, et al.
The American Journal of Cardiology|July 25, 2006
Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial)David A Cox, Gregg W Stone, Cindy L Grines, et al.
American Heart Journal|June 20, 2006
Relationship between infarct artery location, epicardial flow, and myocardial perfusion after primary percutaneous revascularization in acute myocardial infarctionDavid E Kandzari, James E Tcheng, Bernard J Gersh, et al.
Journal of the American College of Cardiology|September 15, 2004
Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trialMichael G McLaughlin, Gregg W Stone, Eve Aymong, et al.
Journal of the American College of Cardiology|July 21, 2004
Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarctionCostantino O Costantini, Gregg W Stone, Roxana Mehran, et al.
Pageof 5